MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration with DKFZ (German Cancer Research Center)
23-Jul-2008 -
MediGene AG announced that, according to plan, an option, granted two years ago by the German Cancer Research Center (Deutsches Krebsforschungszentrum = DKFZ) in Heidelberg for the development and commercialization of an antibody for the treatment of different types of cancer, including ovarian ...
antibodies
Japan
monoclonal antibodies
+4